Haemonetics Corporation (HAE)

Receivables turnover

		Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Revenue	US$ in thousands	2,594,610	2,323,320	985,896	860,363	972,079
Receivables	US$ in thousands	206,562	179,142	159,376	127,555	165,207
Receivables turnover		12.56	12.97	6.19	6.75	5.88

March 31, 2024 calculation

Receivables turnover = Revenue ÷ Receivables
= $2,594,610K ÷ $206,562K
= 12.56

Haemonetics Corporation's receivables turnover has shown fluctuating trends over the past five years. The company's receivables turnover ratio was 12.56 in 2024, indicating that the company collected its accounts receivable approximately 12.56 times during the year. This was a slight decrease from the previous year's ratio of 12.97.

In 2022, the receivables turnover ratio significantly improved to 6.19 compared to 6.75 in 2021, suggesting that the company was able to collect its receivables more efficiently during that period. However, this improvement followed a lower ratio of 5.88 in 2020.

Overall, Haemonetics Corporation's receivables turnover ratio has shown variability, indicating fluctuations in its accounts receivable collection efficiency over the years. Analysis of the underlying reasons for these fluctuations could provide further insights into the company's management of its receivables and its overall financial health.